DE60032827D1 - Verfahren und Oxazolidin Zwischenprodukt zur Herstellung von Taxanen - Google Patents

Verfahren und Oxazolidin Zwischenprodukt zur Herstellung von Taxanen

Info

Publication number
DE60032827D1
DE60032827D1 DE60032827T DE60032827T DE60032827D1 DE 60032827 D1 DE60032827 D1 DE 60032827D1 DE 60032827 T DE60032827 T DE 60032827T DE 60032827 T DE60032827 T DE 60032827T DE 60032827 D1 DE60032827 D1 DE 60032827D1
Authority
DE
Germany
Prior art keywords
preparation
taxanes
oxazolidine intermediate
oxazolidine
baccatines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60032827T
Other languages
English (en)
Other versions
DE60032827T2 (de
Inventor
Ezio Bombardelli
Bruno Gabetta
Alessandro Pontiroli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indena SpA
Original Assignee
Indena SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena SpA filed Critical Indena SpA
Publication of DE60032827D1 publication Critical patent/DE60032827D1/de
Application granted granted Critical
Publication of DE60032827T2 publication Critical patent/DE60032827T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60032827T 1999-07-06 2000-07-03 Verfahren und Oxazolidin Zwischenprodukt zur Herstellung von Taxanen Expired - Lifetime DE60032827T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI001483A ITMI991483A1 (it) 1999-07-06 1999-07-06 Derivati tassanici e procedimenti per la loro preparazione
ITMI991483 1999-07-06

Publications (2)

Publication Number Publication Date
DE60032827D1 true DE60032827D1 (de) 2007-02-15
DE60032827T2 DE60032827T2 (de) 2007-11-08

Family

ID=11383284

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60032827T Expired - Lifetime DE60032827T2 (de) 1999-07-06 2000-07-03 Verfahren und Oxazolidin Zwischenprodukt zur Herstellung von Taxanen
DE60014374T Expired - Lifetime DE60014374T2 (de) 1999-07-06 2000-07-03 Taxan-derivate und verfahren zu ihrer herstellung

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60014374T Expired - Lifetime DE60014374T2 (de) 1999-07-06 2000-07-03 Taxan-derivate und verfahren zu ihrer herstellung

Country Status (23)

Country Link
US (2) US6906101B1 (de)
EP (2) EP1192162B1 (de)
JP (1) JP4823456B2 (de)
KR (1) KR100778156B1 (de)
CN (3) CN1158286C (de)
AT (2) ATE277932T1 (de)
AU (1) AU771737B2 (de)
CA (2) CA2373530C (de)
CZ (1) CZ301764B6 (de)
DE (2) DE60032827T2 (de)
DK (2) DK1529777T3 (de)
ES (2) ES2278254T3 (de)
HK (3) HK1047096A1 (de)
HU (1) HUP0202016A3 (de)
IL (3) IL147445A0 (de)
IT (1) ITMI991483A1 (de)
NO (2) NO328150B1 (de)
PL (1) PL205921B1 (de)
PT (2) PT1529777E (de)
RU (1) RU2245882C2 (de)
SI (2) SI1529777T1 (de)
SK (2) SK287045B6 (de)
WO (1) WO2001002407A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1318678B1 (it) * 2000-08-10 2003-08-27 Indena Spa Procedimento per la preparazione di derivati della baccatina iii.
IT1320107B1 (it) * 2000-11-28 2003-11-18 Indena Spa Procedimento per la preparazione di derivati tassanici.
ITMI20021921A1 (it) * 2002-09-10 2004-03-11 Indena Spa Funzionalizzazione della posizione 14 dei nuclei tassanici e sintesi di nuovi derivati antitumorali.
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
TWI376239B (en) * 2006-02-01 2012-11-11 Andrew Xian Chen Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
US7232916B1 (en) 2006-05-11 2007-06-19 Indena S.P.A. Process for the preparation of a taxane derivative
DK1854799T3 (da) * 2006-05-12 2011-07-18 Indena Spa Fremgangsmåde til fremstilling af et taxanderivat
ITMI20062479A1 (it) * 2006-12-21 2008-06-22 Indena Spa Processo per la preparazione di secotassani
EP2080763A1 (de) 2008-01-18 2009-07-22 INDENA S.p.A. Ortataxel in Kristallform I
ES2389518T3 (es) * 2008-01-18 2012-10-26 Indena S.P.A. Formas sólidas de ortataxel
CN104650109B (zh) * 2013-11-22 2019-01-01 江苏天士力帝益药业有限公司 紫杉烷类化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
US5698712A (en) * 1992-03-06 1997-12-16 Indena S.P.A. Baccatine III derivatives
FR2688499B1 (fr) * 1992-03-10 1994-05-06 Rhone Poulenc Rorer Sa Procede de preparation de la beta-phenylisoserine et de ses analogues.
FR2696460B1 (fr) * 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
US5475011A (en) * 1993-03-26 1995-12-12 The Research Foundation Of State University Of New York Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
US5750508A (en) 1993-06-16 1998-05-12 Glycomed Incorporated Sialic acid/fucose based medicaments
IT1275936B1 (it) * 1995-03-17 1997-10-24 Indena Spa Derivati della 10-deacetilbaccatina iii e della 10-deacetil-14b- idrossibaccatina iii loro metodo di preparazione e formulazioni

Also Published As

Publication number Publication date
ATE277932T1 (de) 2004-10-15
KR20020022759A (ko) 2002-03-27
HK1089158A1 (en) 2006-11-24
DK1192162T3 (da) 2005-01-17
HK1068879A1 (en) 2005-05-06
KR100778156B1 (ko) 2007-11-27
EP1192162B1 (de) 2004-09-29
NO20020017L (no) 2002-02-27
ITMI991483A0 (it) 1999-07-06
SI1192162T1 (en) 2005-02-28
PL205921B1 (pl) 2010-06-30
HUP0202016A2 (en) 2002-10-28
SK12002A3 (en) 2002-04-04
CA2676424A1 (en) 2001-01-11
CN1158286C (zh) 2004-07-21
CN1539831A (zh) 2004-10-27
CZ200222A3 (cs) 2002-05-15
CA2676424C (en) 2011-09-27
IL172973A0 (en) 2006-06-11
ATE350372T1 (de) 2007-01-15
CN100418958C (zh) 2008-09-17
RU2245882C2 (ru) 2005-02-10
EP1529777B1 (de) 2007-01-03
AU5823500A (en) 2001-01-22
HK1047096A1 (en) 2003-02-07
CN1769275A (zh) 2006-05-10
DE60014374D1 (de) 2004-11-04
SK287045B6 (sk) 2009-10-07
SK287046B6 (sk) 2009-10-07
DE60014374T2 (de) 2006-02-16
WO2001002407A3 (en) 2001-06-28
CN1359384A (zh) 2002-07-17
ES2278254T3 (es) 2007-08-01
USRE40901E1 (en) 2009-09-01
IL147445A0 (en) 2002-08-14
PL352278A1 (en) 2003-08-11
CA2373530C (en) 2010-06-29
NO328150B1 (no) 2009-12-21
SI1529777T1 (sl) 2007-04-30
WO2001002407A2 (en) 2001-01-11
NO20093014L (no) 2002-02-27
CN1234696C (zh) 2006-01-04
CZ301764B6 (cs) 2010-06-16
EP1529777A3 (de) 2005-05-18
EP1192162A2 (de) 2002-04-03
PT1192162E (pt) 2004-12-31
CA2373530A1 (en) 2001-01-11
JP2003503502A (ja) 2003-01-28
NO332194B1 (no) 2012-07-23
IL172973A (en) 2010-11-30
IL147445A (en) 2006-07-05
DK1529777T3 (da) 2007-05-14
NO20020017D0 (no) 2002-01-03
EP1529777A2 (de) 2005-05-11
US6906101B1 (en) 2005-06-14
HUP0202016A3 (en) 2005-02-28
ITMI991483A1 (it) 2001-01-06
AU771737B2 (en) 2004-04-01
ES2228560T3 (es) 2005-04-16
DE60032827T2 (de) 2007-11-08
PT1529777E (pt) 2007-01-31
JP4823456B2 (ja) 2011-11-24

Similar Documents

Publication Publication Date Title
HK1068879A1 (en) Taxane derivatives and processes for the preparation thereof
DE69329304D1 (de) Enzymatische Verfahren zur Resolution von Enantiomeren-Mischungen nützlich wie Zwischenprodukte zur Herstellung von Taxanen
ATE280744T1 (de) Verfahren zur herstellung von n-((aliphatisch oder aromatisch)carbonyl)-2-aminoacetamid- verbindungen und deren cyclisierung
DE60140973D1 (de) Kristallines und reines Modafinil und Verfahren zu seiner Herstellung
DE69813523D1 (de) Polyalkoxysiloxanverbindungen,verfahren zur herstellung und diese verbindungen enthaltende beschichtungszusammensetzungen
DE60330703D1 (de) Trans-9,10-dehydroepothilon c und d, analoga davon und verfahren zu deren herstellung
DE60323994D1 (de) Verfahren zur herstellung von 2-chlor-1,1,1,2,3,3,3-heptafluorpropan, hexafluorpropen und 1,1,1,2,3,3,3-heptafluorpropan
DE69231815D1 (de) Verfahren zur Herstellung von Cephalosporinen und Zwischenprodukte in diesem Verfahren
ATE330963T1 (de) Amorphe feste modifikation von bis(2,4- dicumylphenyl) pentaerythritdiphosphit
DE69903252D1 (de) Verfahren zur Herstellung der Taxolanalogen 10-Deacetyltaxol A, B und C
HUP9903318A2 (hu) Intermedierek taxol előállítására
DE60224884D1 (de) Verfahren zur herstellung von 3, 3', 6, 6'-tetraalkylen-2, 2'-biphenolen und 3, 3', 6, 6'-tetraalkylen-5, 5'-dihalo-2, 2' biphenolen
ATE277919T1 (de) Verfahren zur herstellung von baccatin iii- derivativen
ATE251132T1 (de) Verfahren zur herstellung von s-aryl-l-cystein und derivate
ATE267820T1 (de) Prozess zur herstellung von paclitaxel
DE60234630D1 (de) Photochrome oxazinverbindungen und verfahren zu ihrer herstellung
DE60208551D1 (de) Verfahren zur herstellung von racemischen und enantiomerenreinen derivaten von 1,5-diaryl-3-trifluormethyl-delta2-pyrazolinen
DE60236303D1 (de) Verfahren zur herstellung von 14-beta-hydroxybaccatin-iii-1,14-carbonat
DE602004011917D1 (de) Verfahren zur herstellung von 4,10 beta-diacetoxy-2 alpha- benzoyloxy-5 beta, 20-epoxy-1,13 alpha-dihydroxy-9-oxo-19- norcyclopropaäg ütax-11-en
DE60014556D1 (de) Verfahren zur Herstellung von (S)-N-tertbutyl-1,2,3,4- Tetrahydroisochinolin-3-carboxamid
ATE340157T1 (de) Zwischenprodukte, verfahren für deren herstellung und deren gebrauch
ATE302186T1 (de) Derivate von 3-phenyl-2, 6-dioxopiperidin-3-yl propionamide und verfahren zur deren herstellung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC